MEDTRONIC PUERTO RICO OPERATIONS CO. INTELLIS; STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR
|
Back to Search Results |
|
Model Number 97715 |
Device Problems
Intermittent Continuity (1121); Energy Output Problem (1431); Insufficient Information (3190)
|
Patient Problems
Device Overstimulation of Tissue (1991); Insufficient Information (4580)
|
Event Date 10/01/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
G2.Foreign: germany medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Information was received from multiple sources (manufacturer representative, healthcare provider) regarding a patient who was implanted with an implantable neurostimulator (ins).It was reported that the patient complains of insufficient pain relief; therapy not sufficient.Reprogramming was done without solving the complaint, patient is implanted with 5-6-5-surgical lead and is using evolve-settings, 120 s, 6ma, cycling mode.The healthcare provider (hcp) would like to replace the intellis ins with an inceptiv ins to optimize therapy by using ecaps (evoked compound action potentials).The issue was not resolved at the time of the report.The patient status was alive with no injury at the time of the report.Additional information was received from a manufacturer representative (rep).It was reported that the cause of the insufficient pain relief was unclear, the patient complains of insufficient pain relief for months.The parameter settings were changed several times, but the patient is still unhappy.It seems that the patient gets under stimulation.He does not tolerate higher intensity settings or ld-parameters only.The healthcare provider (hcp) thinks that inceptiv with cl, programmed with evolve-settings due to the indication could avoid under stimulation and give sufficient pain relief.The action planned to resolve the issue is replacement of the intellis ins with inceptiv.The provided information has been confirmed with the physician/account.Additional information was received from a manufacturer representative (rep).It was reported that the cause of the insufficient pain relief was due to under or over stimulation, movement depending stimulation.The healthcare provider (hcp) would like to replace the intellis with inceptiv to optimize therapy by using ecaps.The issue has not since been resolved.The provided information has been confirmed with the physician/account.
|
|
Event Description
|
Additional information was received from the rep reporting that the ins replacement is to get a more stable signal.The replacement has not been planned yet.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|